Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.
Gallbladder cancer statistics
New cases of gallbladder cancer, 2014, UK
Deaths from gallbladder cancer, 2014, UK
Survive gallbladder cancer for 10 or more years, 2009-2013, England
- There were around 980 new cases of gallbladder cancer in the UK in 2014, that’s around 3 cases diagnosed every day.
- Gallbladder cancer accounts for less than 1% of all new cases in the UK (2014).
- In males, there were around 250 cases of gallbladder cancer diagnosed in the UK in 2014.
- In females, there were around 720 cases of gallbladder cancer diagnosed in the UK in 2014.
- More than half (52%) of gallbladder cancer cases in the UK each year are diagnosed in people aged 75 and over (2012-2014).
- Incidence rates for gallbladder cancer in the UK are highest in people aged 85+ (2012-2014).
- Since the late 1970s, gallbladder cancer incidence rates have remained stable in Great Britain, for males and females combined and separately.
- Over the last decade, gallbladder cancer incidence rates have increased by more than two-fifths (44%) in the UK, with a similar increase in females (more than two-fifths, 44%) and males (almost a half, 48%).
- 1 in 1,310 men and 1 in 550 women will be diagnosed with gallbladder cancer during their lifetime.
- There were around 570 gallbladder cancer deaths in the UK in 2014, that’s around 2 deaths every day.
- Gallbladder cancer accounts for less than 1% of all cancer deaths in the UK (2014).
- In males in the UK, gallbladder cancer is the 20th most common cause of cancer death, with around 150 deaths in 2014.
- In females in the UK, there were around 420 gallbladder cancer deaths in 2014.
- Almost 6 in 10 (57%) gallbladder cancer deaths in the UK each year are in people aged 75 and over (2012-2014).
- Mortality rates for gallbladder cancer in the UK are highest in people aged 85+ (2012-2014).
- Since the early 1970s, gallbladder cancer mortality rates have decreased by more than two-fifths (44%) in the UK. The decrease is larger in males (48%) than in females (39% decrease).
- Over the last decade, gallbladder cancer mortality rates have increased by around a fifth (21%) in the UK, however this includes stable rates for males and an increase (28%) for females.
- 3 in 20 (15%) people diagnosed with gallbladder cancer in England survive their disease for ten years or more (2009-2013).
- More than 3 in 20 (17%) people diagnosed with gallbladder cancer in England survive their disease for five years or more (2009-2013).
- More than 4 in 10 (43%) people diagnosed with gallbladder cancer in England survive their disease for one year or more (2009-2013).
- Gallbladder cancer 10-year survival in England is similar in men and women (2009-2013).
- Gallbladder cancer survival in England is highest for adults diagnosed aged under 50 years old (2009-2013).
- Around 4 in 10 people in England diagnosed with gallbladder cancer aged 15-49 survive their disease for five years or more, compared with more than a tenth of people diagnosed aged 70-89 (2009-2013).
- Five-year relative survival for gallbladder cancer in men is similar to the European average in England, Wales and Scotland.
- Five-year relative survival for gallbladder cancer in women is similar to the European average in England.
- ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland, and ‘62-day wait’ is not met by any country for upper gastrointestinal cancers.
- More than 8 in 10 patients had a ‘very good’ or ‘excellent’ patient experience.
- Almost 95% of patients are given the name of their Clinical Nurse Specialist.
The latest statistics available for gallbladder cancer in the UK are; incidence 2014, mortality 2014 and survival 2009-2013. Risk factors information are in production.
The ICD code for gallbladder cancer is ICD-10 C23.
European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.
Lifetime risk estimates were calculated using incidence, mortality, population and all-cause mortality data for 2010-2012 due to the small number of cases.
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Gallbladder cancer is part of the group 'Upper Gastrointestinal cancer' for cancer waiting times data. Codes vary per country but broadly include: oesophagus, stomach, liver, gallbladder, other and unspecified parts of biliary tract, pancreas, secondary cancers of liver, intrahepatic bile duct and duodenum.
Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.
You are welcome to reuse this Cancer Research UK statistics content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or